TriSalus Life Sciences In...
(TLSI)
undefined
undefined%
At close: undefined
5.02
-0.99%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | 18.51M | 12.40M | 8.40M | 5.43M |
| Cost of Revenue | 2.60M | 2.26M | 1.19M | 2.20M |
| Gross Profit | 15.91M | 10.14M | 7.21M | 3.24M |
| Operating Income | -54.15M | -36.44M | -24.03M | -25.65M |
| Interest Income | 431.00K | 180.00K | 64.00K | n/a |
| Pretax Income | -59.03M | -47.18M | -28.84M | -31.83M |
| Net Income | -59.04M | -47.19M | -28.84M | -31.83M |
| Selling & General & Admin | 40.55M | 25.22M | 17.02M | 13.06M |
| Research & Development | 29.51M | 21.36M | 14.22M | 15.82M |
| Other Expenses | n/a | -8.73M | 746.00K | n/a |
| Operating Expenses | 70.06M | 46.58M | 31.24M | 29.02M |
| Interest Expense | 16.00K | 1K | 1.76M | n/a |
| Selling & Marketing Expenses | 17.03M | 12.74M | 8.26M | 6.19M |
| Cost & Expenses | 72.66M | 48.84M | 32.43M | 31.22M |
| Income Tax | 9.00K | 9.00K | 3.00K | 4.00K |
| Shares Outstanding (Basic) | 9.40M | 29.61M | 31.25M | 30.56M |
| Shares Outstanding (Diluted) | 9.40M | 29.61M | 31.25M | 30.56M |
| EPS (Basic) | -6.73 | -1.59 | -0.92 | -1.04 |
| EPS (Diluted) | -6.73 | -1.59 | -0.92 | -1.04 |
| EBITDA | -58.30M | -46.76M | -23.57M | -25.32M |
| Depreciation & Amortization | 702.00K | 414.00K | 464.00K | 321.00K |